Antibodies are
referred as proteins produced by plasma cells of the body which are
used by immune system to identify and fight against foreign bodies
entering the host body. Antibodies are also known as immunoglobulin
(Ig). Antibodies are of Y shaped with specific binding site for
specific antigen, a foreign body that provokes an adaptive immune
response. Antibodies are secreted by type of white blood cells (WBCs)
namely, plasma cells.
Immunity strength is
observed to be directly proportional to age. With aging of
population, the number of patients suffering diseases caused by weak
immunity is increasing. Thus, factors such as global increase in the
geriatric population, increasing research and development activity in
the immunology field and availability of the government funds for
research activities are driving the global antibody technologies
market towards growth. On the other hand, lack of funds in developing
economies, stringent regulatory framework and poor adoption of new
technologies are some of the factors restraining the growth of the
global antibody technologies market.
On the grounds of
increased research and development activities globally,
immunofluorescence is the fastest growing segment among the available
research applications. Disease diagnosis segment is leading the
medical application segment due to advancements in research and
thereby entry of improved techniques in the market. Monoclonal
antibodies (mAb or moAb) is leading the segment and is followed by
Intravenous immunoglobulin (IVIg) in the antibody type based antibody
technology segment.
Download Report
Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=33962
Geographically, the
global antibody technologies market is categorized into North
America, Europe, Asia-Pacific and rest of the world regions. North
America currently leads global antibody technologies market and is
followed by Europe. Factors that are fueling the growth of antibody
technology market in the North America include existence of highly
advanced technologies, early adoption of new technologies, developed
healthcare infrastructure and supportive economy. Asia-Pacific is a
lucrative market for antigen technologies and is predicted to undergo
fast market growth. Particularly, countries such as India and China
show growth potential, owing to factors such as government support to
develop biotechnology industry in respective countries, rapidly
improving healthcare infrastructure and increased healthcare
spending.
In addition, Asia
Pacific countries mainly India and China will attract patients on the
grounds of rapidly developing medical tourism industry in these
countries and thereby resulting in increased demand for antibody
technologies market in this region. Some of the major players
contributing to the global antibody technologies market include,
Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd., Biotest AG, Shanghai
RAAS Blood Products Co. Ltd., China Biologic Products, Inc., Bharat
Serums and Vaccines Ltd., OMRIX Biopharmaceuticals Ltd., Kedrion
S.p.A, Beijing Tiantan Biological Products Co. Ltd., Huanlan
Biological Engineering, Inc., Guizhou Taibang Biological Products Co.
Ltd., Grifols S.A., CSL Behring LLC, Baxter International, Inc. and
Octapharma AG.
Pre-Book Full
Report @
https://www.transparencymarketresearch.com/checkout.php?rep_id=33962<ype=S
About Us
Transparency Market
Research (TMR) is a market intelligence company, providing global
business information reports and services. Our exclusive blend of
quantitative forecasting and trends analysis provides forward-looking
insight for thousands of decision makers. TMR’s experienced team of
analysts, researchers, and consultants, use proprietary data sources
and various tools and techniques to gather, and analyze information.
Our business offerings represent the latest and the most reliable
information indispensable for businesses to sustain a competitive
edge.
Each TMR syndicated
research report covers a different sector - such as pharmaceuticals,
chemicals, energy, food & beverages, semiconductors, med-devices,
consumer goods and technology. These reports provide in-depth
analysis and deep segmentation to possible micro levels. With wider
scope and stratified research methodology, TMR’s syndicated reports
strive to provide clients to serve their overall research
requirement.
US Office
Contact
90 State Street,
Suite 700
Albany, NY 12207
Tel:
+1-518-618-1030
USA - Canada Toll
Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment